ABT-751 (Abbott).
Galmarini
Carlos Maria
CM
Centre Regional de Lutte contre le Cancer, Leon Berard, 28 rue Laënnec 69008 Lyon, France. fgalma@rockefeller.univ-lyon.fr
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D013329:Structure-Activity Relationship; D013449:Sulfonamides / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D050257:Tubulin Modulators
C490492:ABT751; D000970:Antineoplastic Agents; D013449:Sulfonamides; D050257:Tubulin Modulators